![Ian Karp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Karp
Investor Relations Contact bij
COLLEGIUM PHARMACEUTICAL, INC.
Profiel
Ian Karp is currently Head-Investor Relations at Collegium Pharmaceutical, Inc. Former positions include Senior Director-Global Marketing at MedImmune LLC, Vice President & Head-Investor Relations at Shire Plc from 2016 to 2017, Senior Vice President-Investor & Public Relations at Karyopharm Therapeutics, Inc., and Senior Vice President-Corporate Communications at Intellia Therapeutics, Inc. Education includes an undergraduate degree from Emory University and an MBA from Rutgers Business School.
Actieve functies van Ian Karp
| Bedrijven | Functie | Begin |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Investor Relations Contact | - |
Eerdere bekende functies van Ian Karp
| Bedrijven | Functie | Einde |
|---|---|---|
| SHIRE | Investor Relations Contact | 01-12-2017 |
| INTELLIA THERAPEUTICS, INC. | Public Communications Contact | - |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Verkoop & Marketing | - |
| KARYOPHARM THERAPEUTICS INC. | Investor Relations Contact | - |
Opleiding van Ian Karp
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
43
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Rutgers Business School
 Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
